Who are the Stakeholders Involved in the Partnership?
The EPPM includes a diverse group of stakeholders, such as: - Healthcare Providers: Hospitals, clinics, and physicians who deliver personalised treatments to patients. - Researchers and Scientists: Individuals and institutions conducting studies to advance personalised medicine. - Pharmaceutical Companies: Firms developing new drugs and therapies tailored to individual patient profiles. - Patients and Patient Advocacy Groups: Ensuring that patient perspectives and needs are central to the partnership's initiatives. - Regulatory Bodies: Agencies responsible for approving and monitoring new personalised therapies.
